Clinical trial

TELI TON - Telithromycin in Tonsillitis

NCT00315042 · Sanofi, Industry · Terminated

Key facts

NCT number NCT00315042
Title TELI TON - Telithromycin in Tonsillitis
Official title Multinational, Randomized, Double-Blind, Double Dummy, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 25mg/kg od Versus 10 Days Penicillin V 13.3 mg/kg Tid in Children 6 Months to Less Than 13 Years With Streptococcus Pyogenes Tonsillitis/Pharyngitis
Lead sponsor Sanofi, Industry
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Tonsillitis, Pharyngitis
Intervention type Drug
Interventions Telithromycin (HMR3647), Penicillin
Enrollment 314
Start date Mar 1, 2006
Primary completion Aug 1, 2006
Completion Aug 1, 2006
First posted Apr 17, 2006
Last update posted Apr 3, 2009
Countries Argentina, Chile, Costa Rica, Panama, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies